Document:

EXHIBIT 10.2

                                CREDIT AGREEMENT

         This CREDIT AGREEMENT, dated as of January 9, 2001 (this "Credit
Agreement"), is by and among Mediconsult.com, Inc., a Delaware corporation
("Mediconsult"), Physicians' Online, Inc., a Delaware corporation and wholly
owned subsidiary of Mediconsult ("Physicians' Online"), and Cybear Inc., a
Delaware corporation ("Cybear") and subsidiary of Andrx Corporation, a Delaware
corporation ("Andrx"). Cybear, Mediconsult and Physicians' Online are
individually referred to as a "Party" and collectively referred to herein as the
"Parties." Terms not defined herein are as defined in the Merger Agreement (as
hereinafter defined).

                                    RECITALS

         A.       Andrx, Mediconsult Acquisition Corp., a Delaware corporation
and wholly owned subsidiary of Andrx ("Merger Sub"), and Mediconsult, entered
into an Agreement and Plan of Merger dated the date hereof (the "Merger
Agreement"), pursuant to which, among other things, upon the terms and subject
to the conditions thereof, Merger Sub will be merged with and into Mediconsult
with Mediconsult continuing as the surviving corporation (the "Merger");

         B.       Pursuant to the Merger Agreement, Andrx has agreed to cause to
be provided to Mediconsult and Physicians' Online interim financing (the "Loan")
in the maximum aggregate principal amount of $2,000,000 (the "Maximum Principal
Amount") to enable Mediconsult and Physicians' Online to fund their operating
activities in the Ordinary Course of Business;

         C.       The Loan is evidenced by that certain Line of Credit
Convertible Note dated of even date herewith (the "Note") made by Mediconsult
and Physicians' Online payable to the order of Cybear; and secured as set forth
herein; and

         D.       Cybear is willing to make the commitment to Mediconsult and
Physicians' Online to make the Loan on the terms and subject to the conditions
hereinafter set forth.

         Now, therefore, in consideration of the premises and the mutual
promises herein made and in consideration of the representations, warranties and
covenants herein contained, the Parties agree as follows:

1.       Line of Credit; Security; Warrant.

         (a) Line of Credit Commitment. Cybear hereby agrees, pursuant to the
terms and subject to the conditions of this Credit Agreement, to make the Loan
to Mediconsult and Physicians' Online for a period beginning on the date hereof
and terminating on July 15, 2001 (the "Maturity Date"), at such times and,
subject to Section 1(b) below, in such amounts as Mediconsult or Physicians'
Online may request up to but not exceeding in the aggregate the Maximum
Principal Amount. No payments under the Note shall be due and payable until the
Maturity Date unless there shall have been an Event of Default.

<PAGE>

         (b) Notice and Manner of Borrowing.

                  (i)      Mediconsult and Physicians' Online shall give written
notice (in the manner set forth in Section 6(a)) to Cybear prior to 10:00 a.m.,
Eastern Time, at least two business days prior to the proposed borrowing date in
substantially the form attached hereto as Exhibit A (the "Notice of Borrowing").
The Notice of Borrowing shall be signed by Mediconsult's Chief Executive Officer
or Chief Financial Officer and countersigned by an authorized representative of
Cybear designated in writing to Mediconsult by Cybear. Each borrowing hereunder
shall be an integral multiple of $50,000. In no event shall the aggregate
borrowings exceed the Maximum Principal Amount. Neither Mediconsult nor
Physicians' Online shall give a Notice of Borrowing more frequently than
biweekly.

                  (ii)     Each borrowing under this Section 1 shall be made at
the principal business office of Cybear, at its address set forth herein, by
crediting Mediconsult's or Physicians' Online's account designated in the Notice
of Borrowing in the amount thereof. If each of the conditions set forth in
Section 1(d) have been satisfied, the proceeds of the borrowing shall be
available to Mediconsult and Physicians' Online prior to 2:00 p.m., Eastern
Time, on such borrowing date.

                  (iii)    Mediconsult and Physicians' Online shall have the
right, at any time and from time to time, to prepay the Loan, in whole or in
part, without penalty or premium, upon not less than three business days' notice
to Cybear, provided, however, that, upon each prepayment, Mediconsult and
Physicians' Online shall pay accrued interest on the principal amount so repaid
to the date of prepayment.

         (c) Note. The Loan made by Cybear under this Section shall be evidenced
by, and repaid with interest in accordance with, the Note. The Note shall be
enforceable, with respect to Mediconsult's and Physicians' Online's obligation
to pay the principal amount thereof, only to the extent of the unpaid principal
amount of the Loan at the time evidenced thereby. Interest on the Note shall be
payable on, and only for the period during which, the principal amount of the
Loan evidenced thereby is outstanding.

         (d) Conditions to Loan. The obligation of Cybear to make the Loan is
subject to the following conditions precedent, each of which shall have been met
or performed by the borrowing date with respect to such Loan:

                  (i)      Notice of Borrowing. Mediconsult and Physicians'
Online shall have delivered to Cybear the Notice of Borrowing.

                  (ii)     No Default. No default or Event of Default (as
defined in Section 5 herein) shall have occurred and be continuing or will occur
upon the making of the Loan on such borrowing date, and the representations and
warranties in Section 2 of this Credit Agreement shall be true and correct in
all material respects with the same effect as though such representations and
warranties had been made on and as of such borrowing date.

         (e) Security. The Note shall be secured by (A) a pledge of all of the
issued and outstanding common stock of Physicians' Online (the "POL Stock")
pursuant to a Stock Pledge Agreement, in substantially the form attached hereto
as Exhibit B (the "Pledge Agreement"); and

                                       2
<PAGE>

(B) a security interest in all the assets of Physicians' Online pursuant to a
Security Agreement, in substantially the form attached hereto as Exhibit C (the
"Security Agreement").

         (f) Warrant. Simultaneously with the execution of this Credit
Agreement, Mediconsult shall issue to Cybear a warrant, in substantially the
form attached hereto as Exhibit D (the "Warrant"), to purchase 8,926,502 shares
of common stock, $.001 par value per share, of Mediconsult (the "Mediconsult
Common Stock").

         (g) Financial Condition Certificate. Simultaneously with the execution
of this Credit Agreement, Mediconsult shall deliver to Cybear a certificate
executed by the Chief Financial Officer of Mediconsult regarding the
consolidated financial condition of Mediconsult, in substance reasonably
satisfactory to Cybear.

2.       Representations And Warranties. In order to induce Cybear to enter into
this Credit Agreement and to make the Loan, Mediconsult represents and warrants
to Cybear that the statements contained in this Section 2 are correct and
complete as of the date of this Credit Agreement and will be correct and
complete as of each borrowing date, except as set forth in the Disclosure
Schedules to the Merger Agreement.

         (a) Organization, Qualification, and Corporate Power. Each of
Mediconsult and its Subsidiaries is a corporation duly organized, validly
existing, and in good standing under the laws of the jurisdiction of its
incorporation. Each of Mediconsult and its Subsidiaries is duly authorized to
conduct business and is in good standing under the laws of each jurisdiction
where such qualification is required, except where the lack of such
qualification would not have a material adverse effect on the business,
operations, results of operations, assets, liabilities or financial condition of
Mediconsult or Physicians' Online, or on the ability of the Parties to
consummate the transactions contemplated by the Merger Agreement (a "Mediconsult
Material Adverse Effect"); it being understood, however, that Mediconsult's
continuing to incur losses in the Ordinary Course of Business, shall not, alone,
be deemed to be a Mediconsult Material Adverse Effect. Each of Mediconsult and
its Subsidiaries have full corporate power and authority to carry on the
businesses in which it is engaged and to own and use the properties owned and
used by it. Mediconsult is the owner of the POL Stock, and all such shares are
duly authorized, validly issued, fully paid and nonassessable. The POL Stock is
owned by Mediconsult, free and clear of all Security Interests or rights of
others.

         (b) Authorization of Transaction. Mediconsult and Physicians' Online
each has full power and authority (including full corporate power and authority)
to execute and deliver the Note, Credit Agreement, Pledge Agreement, Security
Agreement and Warrant, as the case may be, and to perform its obligations
hereunder. The Note, Credit Agreement, Pledge Agreement, Security Agreement and
Warrant constitute the valid and legally binding obligation of Mediconsult and
Physicians' Online, as the case may be, enforceable against Mediconsult or
Physicians' Online, as the case may be, in accordance with their terms except as
such enforcement may be limited by (i) the effect of bankruptcy, insolvency,
reorganization, receivership, conservatorship, arrangement, moratorium or other
laws affecting or relating to the rights of creditors generally, or (ii) the
rules governing the availability of specific performance, injunctive relief or
other equitable remedies and general principles of equity, regardless of whether
considered in a proceeding in equity or at law.

                                       3
<PAGE>

         (c) Noncontravention. Neither the execution and the delivery of the
Note, Credit Agreement, Pledge Agreement, Security Agreement or Warrant, nor the
consummation of the transactions contemplated hereby, will (i) violate any
constitution, statute, regulation, rule, injunction, judgment, order, decree,
ruling, charge, Governmental Permit or other restriction of any Governmental
Entity, or court to which any of Mediconsult and its Subsidiaries is subject;
(ii) violate any provision of the charter or bylaws of any of Mediconsult and
its Subsidiaries or (iii) conflict with, result in a breach of, constitute a
default under, result in the acceleration of, create in any party the right to
accelerate, terminate, modify, or cancel, or require any notice under any
agreement, contract, lease, license, instrument or other arrangement to which
any of Mediconsult and its Subsidiaries is a party or by which it is bound or to
which any of its assets is subject (or result in the imposition of any Security
Interest upon any of its assets), except, in the cases of (i) and (iii), where
the violation, conflict, breach, default, acceleration, termination,
modification, cancellation, or failure to give notice would not have a
Mediconsult Material Adverse Effect. None of Mediconsult and its Subsidiaries
are required to give any notice to, make any filing with, or obtain any
authorization, consent, or approval of any government or Governmental Entity in
order for the Parties to consummate the transactions contemplated by this Credit
Agreement.

         (d) Financial Statements. The Mediconsult Financial Statements were
complete and correct in all material respects as of their respective dates,
comply in all material respects with the Securities Exchange Act and the rules
and regulations of the SEC promulgated thereunder and have been prepared in
accordance with GAAP applied on a consistent basis throughout the periods
covered thereby (except as may be indicated in the notes thereto or, in the case
of unaudited financial statements, as may be permitted by the SEC on Form 10-Q
under the Securities Exchange Act), present fairly the financial condition of
Mediconsult and its Subsidiaries as of the indicated dates and the results of
operations of Mediconsult and its Subsidiaries for the indicated periods, are
correct and complete in all material respects as of their respective dates, and
are consistent with the books and records of Mediconsult and its Subsidiaries,
except that the unaudited interim financial statements were or are subject to
normal and recurring year-end adjustments which were not, or are not expected to
be, material in amount.

         (e) Events Subsequent to Most Recent Mediconsult Fiscal Period End.
Since the Most Recent Mediconsult Fiscal Period End, Mediconsult has conducted
its business in the Ordinary Course of Business and there has not occurred, (i)
any change, event or condition (whether or not covered by insurance) that has
resulted in, or would result in, a Mediconsult Material Adverse Effect;
provided, however, that for purposes of this Section 2(e), the occurrence of any
of the following events or circumstances, in and of themselves and in
combination with any of the others, shall not constitute a Mediconsult Material
Adverse Effect: (A) circumstances, changes in, or effects on Mediconsult or its
business caused by (x) changes in its business plan or methods of operations
made at the request of Andrx or Cybear or (y) actions taken or decisions made by
Andrx or Cybear, (B) any adverse change, event or effect that is caused
primarily by conditions generally affecting the United States economy, (C) any
adverse change, event or effect that is caused primarily by conditions generally
affecting the healthcare, technology, Internet or service industries; or (D) any
adverse change that is demonstrated to be attributable primarily to the
announcement or discovery of this Credit Agreement and the transactions
contemplated hereby (including employee attrition or any loss of business
relationships), unless such change resulted from a breach by Mediconsult or its
obligations under this Credit

                                       4
<PAGE>

Agreement; (ii) any acquisition, sale or transfer of any asset material to the
ongoing business of Mediconsult or any of its Subsidiaries other than in the
Ordinary Course of Business; (iii) any change in accounting methods or practices
(including any change in depreciation or amortization policies or rates) by
Mediconsult, except as required by concurrent changes in GAAP or any revaluation
by Mediconsult of any of its or any of its Subsidiaries' assets, except as
required by GAAP; (iv) any declaration, setting aside, or payment of a dividend
or other distribution with respect to the Mediconsult Capital Stock, or any
direct or indirect redemption, purchase or other acquisition by Mediconsult of
any of its shares of the Mediconsult Capital Stock; (v) any contract entered
into by Mediconsult or any of its Subsidiaries, other than in the Ordinary
Course of Business, or any amendment or termination of, or default under, any
contract to which Mediconsult or any of its Subsidiaries is a party or by which
it is bound; (vi) any amendment or change to the Mediconsult Certificate of
Incorporation or bylaws of Mediconsult; (vii) any increase in or modification
(other than a decrease in compensation or other benefits) of the compensation or
benefits payable or to become payable by Mediconsult to any of its directors,
officers or employees (except in the case of employees (other than officers)
increases (x) in the Ordinary Course of Business or (y) as required by any
relevant employee agreement or option agreement); (viii) any change in the
interest rate risk management and hedging policies, procedures or practices of
Mediconsult or any of its Subsidiaries, or any failure to comply with such
policies, procedures and practices; or (ix) any negotiation or agreement by
Mediconsult or any of its Subsidiaries to do any of the things described in the
preceding clauses (i) through (viii) (other than negotiations with Andrx or
Cybear and its representatives regarding the transactions contemplated by the
Merger Agreement or this Credit Agreement).

         (f) Undisclosed Liabilities. Neither Mediconsult nor any of its
Subsidiaries has any obligations or liabilities (contingent or otherwise) except
obligations and liabilities (i) that are fully accrued or provided for in all
material respects in the Mediconsult Balance Sheet in accordance with GAAP, or
disclosed in the notes therein in accordance with GAAP or (ii) that were
incurred after the Most Recent Mediconsult Fiscal Period End in the Ordinary
Course of Business (none of which results from, arises out of, relates to, is in
the nature of, or was caused by any breach of contract, breach of warranty,
tort, infringement, or violation of law). All material agreements currently in
effect, including all material agreements, arrangements or understandings with
directors and officers of Mediconsult, are filed as exhibits to Mediconsult
Public Reports.

         (g) Litigation. Neither Mediconsult nor any of its Subsidiaries is (i)
subject to any outstanding injunction, judgment, order, decree, ruling, or
charge, which would have a Mediconsult Material Adverse Effect, or (ii) a party
to or, to Mediconsult's Knowledge, threatened to be made a party to, any action,
suit, proceeding, hearing, or investigation of, in, or before any Governmental
Entity or before any arbitrator which would have a Mediconsult Material Adverse
Effect.

         (h) Restrictions on Business Activities. There is no agreement,
judgment, injunction, order or decree binding upon Mediconsult or any of its
Subsidiaries which has had or would have the effect of prohibiting or impairing
any current business practice of Mediconsult or any of its Subsidiaries, any
acquisition of property by Mediconsult or any of its Subsidiaries or the conduct
of business by Mediconsult or any of its Subsidiaries as currently conducted by
Mediconsult or any of its Subsidiaries.

                                       5
<PAGE>

         (i) Compliance With Laws. Each of Mediconsult and its Subsidiaries has
complied in all respects with all applicable federal, state, local,
self-regulatory and foreign laws, statutes, ordinances, rules and regulations,
and is not in violation in any respect of, and has not received any notices of
violation with respect to, its respective certificate or articles of
incorporation or bylaws or other charter or organizational documents, each as
amended, or any federal, state, local, self-regulatory or foreign statute, law,
ordinance, rule or regulation applicable to the conduct of its business or the
ownership or operation of its business, except where such noncompliance or
violation would not have a Mediconsult Material Adverse Effect.

         (j) Representations Complete. None of the representations or warranties
made by Mediconsult herein or in any schedule hereto, or certificate furnished
by Mediconsult pursuant to this Credit Agreement, when all such documents are
read together in their entirety, contains or will contain on the date hereof or
on a borrowing date any untrue statement of a material fact, or omits or will
omit on the date hereof or on a borrowing date to state any material fact
necessary in order to make the statements contained herein or therein, in the
light of the circumstances under which made, not misleading.

3.       Affirmative Covenants. Mediconsult and Physicians' Online covenant and
agree with Cybear that, from the date hereof and so long as this Credit
Agreement remains in effect, or any obligations under the Loan or the Note
remain outstanding and unpaid, unless Andrx or Cybear shall otherwise consent in
writing, Mediconsult and Physicians' Online will:

         (a) Corporate Existence. Do or cause to be done all things necessary to
preserve, renew and keep in full force and effect the corporate existence of
Mediconsult and, except as requested or permitted by Cybear, its Subsidiaries,
and all rights, licenses, permits and franchises required as of the date hereof,
or which may be required in the future, for the conduct of Mediconsult's
business and comply with all applicable laws and regulations that materially
affect Mediconsult and its Subsidiaries and maintain, preserve and protect all
franchises, trade names and all property used or required in the conduct of
Mediconsult's business, except to the extent failure to do any of the foregoing
would not have a Mediconsult Material Adverse Effect.

         (b) Insurance. Keep the insurable properties used in Mediconsult's and
Physicians' Online's business insured in accordance and consistent with past
practice.

         (c) Obligations and Taxes. Promptly pay and discharge, or cause to be
paid and discharged, all Taxes imposed upon Mediconsult and its Subsidiaries and
their respective properties, and all lawful claims of labor, materials and
supplies or otherwise that, if unpaid, might become a Security Interest upon
such properties (other than Permitted Liens as defined in Section 4(c) herein);
provided, however, that Mediconsult shall not be required to pay and discharge,
or cause to be paid and discharged, any such Tax so long as the validity thereof
shall be contested in good faith by appropriate proceedings.

         (d) Books and Records. Keep and maintain full and accurate accounts and
records of Mediconsult's operations according to GAAP consistently applied on a
basis consistent with past practices, and permit Cybear reasonable access
thereto.

         (e) Notice of Default. Upon the occurrence of any default under this
Credit Agreement or Event of Default (as defined in Section 5 herein) or any
event which, with the lapse of time or the giving of notice, or both, would
constitute an Event of Default, under this Credit Agreement

                                       6
<PAGE>

or the Note, furnish, within two business days after each such occurrence,
written notice thereof to Cybear specifying the nature and period of existence
thereof and the action that Mediconsult or Physicians' Online is taking or
proposes to take with respect thereto.

         (f) Interim Financial Statements; Collateral Reports.

                  (i)      Within 10 business days after the close of each
calendar month, furnish Cybear with unaudited monthly and year-to-date financial
statements of Mediconsult, consisting of consolidated balance sheets and
operating statements and a listing of all contingent liabilities of Mediconsult
for the periods involved and such other statements as Cybear may request,
prepared in accordance with GAAP applied on a basis consistent with the
Mediconsult Financial Statements, taken from the books and records of
Mediconsult, and certified as correct by the Chief Financial Officer of
Mediconsult.

                  (ii)     Within 20 business days after the close of each
calendar month, furnish Cybear with such financial reports as of the middle of
the current month that are mutually and reasonably acceptable in form to both
Mediconsult and Cybear, taken from the books and records of Mediconsult and
certified as correct by the Chief Financial Officer of Mediconsult.

                  (iii)    At the time of furnishing each of such financial
statements or reports, Mediconsult shall furnish Cybear with a certificate from
the President or Chief Financial Officer of Mediconsult stating that he has
reviewed this Credit Agreement and the affairs of Mediconsult and that to the
best of his knowledge and belief he is unaware of the occurrence of an event
which constitutes an Event of Default hereunder or which would constitute such
an Event of Default with the giving of notice or the lapse of time or both, and
if so, stating the facts with respect thereto.

         (g) Compliance with Laws. Comply in all respects with all federal,
state, local, self-regulatory and foreign laws, statutes, ordinances, rules and
regulations, except as would not have a Mediconsult Material Adverse Effect.

         (h) Full Access. Mediconsult will (and will cause each of its
Subsidiaries to) permit representatives of Cybear to have reasonable full access
during normal business hours, upon reasonable notice, to all premises,
properties, personnel, books, records (including Tax records), contracts, and
documents of or pertaining to each of Mediconsult and its Subsidiaries during
the period prior to the Maturity Date; provided that Cybear and its
representatives will conduct any such review in a manner that does not interfere
with the normal business operations of Mediconsult. Cybear will (and will cause
each of its employees, agents or other representatives to) treat and hold as
such any Confidential Information it receives from any of Mediconsult and its
Subsidiaries in the course of the reviews contemplated by this Section 3(h),
will not use any of the Confidential Information except in connection with the
Merger Agreement or this Credit Agreement, and, if the Merger Agreement and this
Credit Agreement are terminated for any reason whatsoever, agrees to return to
Mediconsult all tangible embodiments (and all copies) thereof which are in its
possession. The provisions of this Section 3(h) relating to the Confidential
Information will survive any termination of this Credit Agreement.

         (i) Maintenance of Properties. Keep its properties in good repair,
working order and condition, reasonable wear and tear excepted, and from time to
time make all needed and proper repairs, renewals, replacements, additions, and
improvements thereto and comply (other than as

                                       7
<PAGE>

agreed between Mediconsult and its landlords) with the provisions of all leases
to which it is a party or under which it occupies property so as to prevent any
loss or forfeiture thereof or thereunder.

         (j) Additional Documents. Join Cybear in executing any security
agreements, assignments, consents, financing statements or other instruments, in
form reasonably satisfactory to Cybear, as Cybear may from time to time request.

         (k) Notice to Cybear. Within two business days after its occurrence,
notify Cybear (i) of any event causing a material loss or depreciation in value
of any collateral and the amount of such loss or depreciation, or (ii) of any
lawsuit involving Mediconsult.

         (l) Use of Loan Proceeds. Except as contemplated by the Merger
Agreement, use the proceeds of the Loan only to fund the operating activities of
Mediconsult or Physicians' Online in the Ordinary Course of Business.

                  4.       Negative Covenants. Mediconsult and Physicians'
Online covenant and agree with Cybear that, from the date hereof and so long as
this Credit Agreement remains in effect, or any obligations under the Loan or
the Note remain outstanding and unpaid, unless Andrx or Cybear shall otherwise
consent in writing, Mediconsult and Physicians' Online will not:

         (a) Ordinary Course of Business. Except as contemplated by the Merger
Agreement, make any payments to (i) satisfy any closing conditions set forth in
Section 7 of the Merger Agreement, (ii) pay any severance obligations which are
not being paid as of the date hereof, or (iii) pay any extraordinary expenses
outside the Ordinary Course of Business.

         (b) Indebtedness. Issue any note, bond, or other debt security or
create, incur, assume, or guarantee any indebtedness for borrowed money or
capitalized lease obligation outside the Ordinary Course of Business, except (i)
any loan arrangements between Mediconsult and Andrx or any of its Subsidiaries
or Affiliates, (ii) in connection with the financing of working capital in the
Ordinary Course of Business, (iii) the incurrence of long-term indebtedness in
connection with the refinancing of existing indebtedness either at its stated
maturity or at a lower cost of funds in the Ordinary Course of Business (iv) the
incurrence of short-term indebtedness in the Ordinary Course of Business, (v)
indebtedness incurred to finance activities permitted by Section 4(d)(iv) and
(d)(vi), or (vi) as otherwise permitted by the Merger Agreement.

         (c) Security Interests. Create, incur, assume, or suffer to exist any
Security Interest, or charge of any kind (including charges on property
purchased under conditional sales or other title retention agreements) on any of
its property or assets, now owned or hereafter acquired, except for the
following (all of which are referred to herein as "Permitted Liens"):

                  (i)      Security Interests for taxes, assessments, or similar
charges, incurred in the Ordinary Course of Business that are not yet due and
payable (excluding any Security Interests imposed pursuant to any of the
provisions of ERISA);

                  (ii)     Other Security Interests incurred in the Ordinary
Course of Business and created by operation of law;

                                       8
<PAGE>

                  (iii)    Good faith pledges or deposits made in the Ordinary
Course of Business to secure performance of bids, tenders, contracts (other than
for the repayment of borrowed money), or leases (other than leases intended as
security for indebtedness), or to secure statutory obligations, or surety,
appeal, indemnity, performance or other similar bonds (not intended as security
for indebtedness for money borrowed) required in the Ordinary Course of
Business;

                  (iv)     Purchase money Security Interests and encumbrances
created to secure the indebtedness permitted by Section 4(b) hereof; and

                  (v)      Security Interests in favor of Cybear.

         (d) Operation of Business. Except as permitted by the Merger Agreement,
engage in any practice, take any action, or enter into any transaction outside
the Ordinary Course of Business. Without limiting the generality of the
foregoing:

                  (i)      none of Mediconsult and its Subsidiaries will
authorize or effect any change in its charter or bylaws;

                  (ii)     except as set forth on Disclosure Schedule 6(d) of
the Merger Agreement, none of Mediconsult and its Subsidiaries will grant any
options, warrants, or other rights to purchase or obtain any of its capital
stock or issue, sell, or otherwise dispose of any of its capital stock (except
upon the conversion or exercise of options, warrants, and other rights currently
outstanding);

                  (iii)    none of Mediconsult and its Subsidiaries will
declare, set aside, or pay any dividend or distribution with respect to the
Mediconsult Capital Stock (whether in cash or in kind), or split, combine,
reclassify, redeem, repurchase, or otherwise acquire, directly or indirectly,
Mediconsult Capital Stock;

                  (iv)     none of Mediconsult and its Subsidiaries will make
any capital investment in, make any loan to, or acquire the securities or assets
of any other Person outside the Ordinary Course of Business;

                  (v)      none of Mediconsult and its Subsidiaries will make
any capital expenditures outside the Ordinary Course of Business;

                  (vi)     except as set forth on Disclosure Schedule 6(d) of
the Merger Agreement, none of Mediconsult and its Subsidiaries will make any
change in employment terms for any of its directors or executive officers, or
enter into any other arrangement or agreement with directors or executive
officers, and none of Mediconsult and its Subsidiaries will make any change in
employment terms for any of its employees outside the Ordinary Course of
Business;

                  (vii)    except as set forth on Disclosure Schedule 6(d) of
the Merger Agreement, none of Mediconsult and its Subsidiaries will sell or
transfer to any Person any material rights to Mediconsult's Intellectual
Property, purchase any material right to Intellectual Property or enter into any
material license agreement with any Person with respect to Mediconsult's
Intellectual Property outside the Ordinary Course of Business; and

                                       9
<PAGE>

                  (viii)   none of Mediconsult and its Subsidiaries will commit
to any of the foregoing.

         (e) Financing Statements. Except as set forth on Schedule 4(e) to this
Credit Agreement, permit any financing statement (except Cybear's financing
statements and those with respect to the Permitted Liens) to be on file with
respect to the collateral.

         (f) Location of Collateral. Except as agreed by Mediconsult and Cybear,
change the locations at which the collateral is maintained; change the name,
identity, or corporate structure of Mediconsult; adopt or make use of any
fictitious or trade name not disclosed elsewhere in this Credit Agreement; or
change the location of its chief executive office.

         (g) Destruction of Collateral. Waste or destroy the collateral or use
it in violation of any law, statute or ordinance.

         (h) Agreements. Enter into any agreement involving (i) the payment by
Mediconsult to a third party of more than $10,000 or (ii) the receipt by
Mediconsult from a third party of more than $25,000.

         (i) Adverse Transactions. Enter into any transaction, or permit any
Subsidiary to enter into any transaction, permit or agree to any extension,
compromise or settlement, or make any change or modification of any kind or
nature with respect to any account, including any of the terms relating thereto,
other than discounts and allowances in the Ordinary Course of Business, in any
such case which materially and adversely affects or would reasonably be expected
to materially and adversely affect the collateral or Mediconsult's ability to
repay the obligations.

5.       Events of Default. If any one of the following "Events of Default"
shall occur:

         (a) Mediconsult or Physicians' Online shall fail to pay, when due, any
principal of or interest on the Loan, or to pay when due (whether by
acceleration, maturity or otherwise) any other sum payable under this Credit
Agreement;

         (b) Mediconsult shall fail to cure any of the following within ten
business days after written notice thereof from Cybear:

                  (i)      Any representation or warranty made by Mediconsult
herein or in any certificate or report furnished by Mediconsult or Physicians'
Online hereunder shall prove to have been incorrect in any material respect;

                  (ii)     Mediconsult or Physicians' Online shall breach any
agreement, covenant or obligation contained herein;

                  (iii)    Mediconsult shall breach any provision of the Note,
the Pledge Agreement or the Merger Agreement;

                  (iv)     Physicians' Online shall breach any provision of the
Note or Security Agreement;

                                       10
<PAGE>

         (c) The Merger Agreement is terminated pursuant to Section 8 thereof,
other than pursuant to Section 8(a)(ii)(B) or 8(a)(iii);

         (d) Mediconsult or Physicians' Online shall: (i) voluntarily terminate
operations or apply for or consent to the appointment of, or the taking of
possession by, a receiver, custodian, trustee or liquidator of Mediconsult or
Physicians' Online or of all or a substantial part of the assets of Mediconsult
or Physicians' Online, (ii) admit in writing its inability, or be generally
unable, to pay its debts as the debts become due, (iii) make a general
assignment for the benefit of its creditors, (iv) commence a voluntary
proceeding under the United States Bankruptcy Code (as now or hereafter in
effect), (v) file a petition seeking to take advantage of any other law relating
to bankruptcy, insolvency, reorganization, winding-up, or composition or
adjustment of debts, (vi) fail to controvert in a timely and appropriate manner,
or acquiesce in writing to, any petition filed against it in an involuntary
proceeding under the Bankruptcy Code, or (vii) take any corporate action for the
purpose of effecting any of the foregoing; or

         (e) Without Mediconsult's or Physicians' Online's application, approval
or consent, a proceeding shall be commenced, in any court of competent
jurisdiction, seeking in respect of Mediconsult or Physicians' Online: the
liquidation, reorganization, dissolution, winding-up, or composition or
readjustment of debt, the appointment of a trustee, receiver, liquidator or the
like of Mediconsult or Physicians' Online, or of all or any substantial part of
the assets of Mediconsult or Physicians' Online, or other like relief in respect
of Mediconsult or Physicians' Online, under any law relating to bankruptcy,
insolvency, reorganization, winding-up, or composition or adjustment of debts,
unless such proceeding is contested in good faith by Mediconsult or Physicians'
Online; and, if the proceeding is being contested in good faith by Mediconsult
or Physicians' Online, the same shall continue undismissed, or unstayed and in
effect, for any period of 60 consecutive calendar days, or an order for relief
against Mediconsult or Physicians' Online shall be entered in any involuntary
proceeding under the United States Bankruptcy Code.

         THEREUPON, in the case of any such event other than an event described
in Section 5(d) or 5(e), Cybear may, by written notice to Mediconsult or
Physicians' Online: (i) immediately terminate the Loan hereunder, and/or (ii)
immediately declare the principal of, and interest accrued on, the Loan
forthwith due and payable, whereupon the same shall become immediately due and
payable; and, in the case of any event described in Section 5(d) or 5(e), the
Loan hereunder shall automatically terminate, without any action on the part of
Cybear, and the principal of, and accrued interest on, the Loan shall become
immediately due and payable, both as to principal and interest, without
presentment, demand, protest, or other notice of any kind, all of which are
hereby expressly waived, anything contained herein or in the Note to the
contrary notwithstanding.

         Upon the happening and continuance of any Event of Default specified in
this Credit Agreement, Cybear may proceed to protect and enforce its rights
under this Credit Agreement by such suits, actions or special proceedings in
equity or at law, either for specific performance of any covenant or agreement
contained herein or in aid of execution of any power herein or therein granted
or for the enforcement of any proper legal or equitable remedy, as Cybear shall
deem most effectual to protect and enforce such rights.

                                       11
<PAGE>

         In the enforcement of any remedy described above, Cybear shall be
entitled to sue for, enforce payment of and receive any and all amounts then or
during any Event of Default becoming or remaining due from Mediconsult and
Physicians' Online for principal, interest or otherwise under any of the
provisions of this Credit Agreement or the Note, together with interest on
overdue payments at a rate equal to 2% higher than the rate otherwise applicable
(the "Default Rate") and all costs and expenses of collection and of all
proceedings hereunder.

         Any monies received by Cybear by exercise of its rights and remedies
provided for in this Section 5 or otherwise, shall be applied by Cybear as
follows: first, to the payment of the costs and expenses (including reasonable
attorneys' fees) incurred by Cybear in connection with the exercise of such
rights and remedies; second, any surplus to the pro rata payment of the
indebtedness of Mediconsult and Physicians' Online to Cybear in accordance with
the provisions of this Credit Agreement and in such order as to principal,
interest and other sums as Cybear may determine; and third, any surplus to
Mediconsult and Physicians' Online.

6.       Miscellaneous.

         (a) Notices. All notices, requests, demands, claims, and other
communications hereunder will be in writing. Any notice, request, demand, claim,
or other communication hereunder shall be deemed duly given if (and then two
business days after) it is sent by registered or certified mail, return receipt
requested, postage prepaid, and addressed to the intended recipient as set forth
below:

                    If to Mediconsult or Physicians' Online:
                    ----------------------------------------

                                  Ian Sutcliffe
                        560 White Plains Road, 4th Floor
                            Tarrytown, New York 10591
                            Telephone: (914) 332-6100
                            Facsimile: (914) 332-6445

                                    Copy to:
                                    --------

                                E. Michael Ingram
                        560 White Plains Road, 4th floor
                            Tarrytown, New York 10591
                            Telephone: (914) 332-6100
                            Facsimile: (413) 826-4026

                                       and

                                       12
<PAGE>

                              Scott F. Smith, Esq.
                             Covington & Burlington
                           1330 Avenue of the Americas
                            New York, New York 10019
                            Telephone: (212) 841-1000
                            Facsimile: (212) 841-1010

                                  If to Cybear:
                                  -------------

                                Scott Lodin, Esq.
                                Andrx Corporation
                                4955 Orange Drive
                                 Davie, FL 33314
                            Telephone: (954) 584-0300
                            Facsimile: (954) 792-1034

                                    Copy to:
                                    --------

                              Dale S. Bergman, Esq.
                                Broad and Cassel
                                   Suite 3000
                            201 South Biscayne Blvd.
                                 Miami, FL 33131
                            Telephone: (305) 373-9400
                            Facsimile: (305) 373-9493

         Any Party may send any notice, request, demand, claim, or other
communication hereunder to the intended recipient at the address set forth above
using any other means (including personal delivery, expedited courier, messenger
service, telecopy, telex, ordinary mail, or electronic mail), but no such
notice, request, demand, claim, or other communication shall be deemed to have
been duly given unless and until it actually is received by the intended
recipient. Any Party may change the address to which notices, requests, demands,
claims, and other communications hereunder are to be delivered by giving the
other Party notice in the manner herein set forth.

         (b) Survival of Representations. All representations and warranties
made herein shall survive the making of the Loan hereunder and the delivery of
the Note, and shall continue in full force and effect so long as the Note is
outstanding and unpaid and the Loan shall have not been terminated in full.

         (c) Governing Law. This Credit Agreement shall be governed by and
construed in accordance with the domestic laws of the State of Delaware, without
giving effect to any choice or conflict of law provision or rule (whether of the
State of Delaware or any other jurisdiction) that would cause the application of
the laws of any jurisdiction other than the State of Delaware.

         (d) Headings The section headings contained in this Credit Agreement
are inserted for convenience only and shall not affect in any way the meaning or
interpretation of this Credit Agreement.

                                       13
<PAGE>

         (e) Amendments, Waivers and Remedies Cumulative. The Parties may
mutually amend any provision of this Credit Agreement at any time prior to the
Maturity Date. No amendment of any provision of this Credit Agreement shall be
valid unless the same shall be in writing and signed by all of the Parties. No
waiver by any Party of any default, misrepresentation, or breach of warranty or
covenant hereunder, whether intentional or not, shall be deemed to extend to any
prior or subsequent default, misrepresentation, or breach of warranty or
covenant hereunder or affect in any way any rights arising by virtue of any
prior or subsequent such occurrence. The remedies herein provided and in the
Note are cumulative and are not exclusive of any remedies provided by law. To
the extent that there is any conflict between the provisions of this Credit
Agreement and the Note, the provisions of this Credit Agreement shall prevail.

         (f) Severability Any term or provision of this Credit Agreement that is
invalid or unenforceable in any situation in any jurisdiction shall not affect
the validity or enforceability of the remaining terms and provisions hereof or
the validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction. The Parties further agree to replace
such invalid or unenforceable provision of this Credit Agreement with a valid
and enforceable provision that will achieve, to the extent possible, the
economic, business and other purposes of such invalid or unenforceable
provision.

         (g) Expenses. Except as otherwise provided in this Credit Agreement,
all costs and expenses in connection with this Credit Agreement and the
transactions contemplated hereby (including, without limitation, the fees and
expenses of its advisors, brokers, finders, agents, accountants and legal
counsel) shall be paid by the Party incurring such expense. Mediconsult shall
pay any stamp and other taxes payable in connection with the execution and
delivery of this Credit Agreement and the Note.

         (h) Construction. The Parties have participated jointly in the
negotiation and drafting of this Credit Agreement. In the event an ambiguity or
question of intent or interpretation arises, this Credit Agreement shall be
construed as if drafted jointly by the Parties and no presumption or burden of
proof shall arise favoring or disfavoring any Party by virtue of the authorship
of any of the provisions of this Credit Agreement. Any reference to any federal,
state, local, or foreign statute or law shall be deemed also to refer to all
rules and regulations promulgated thereunder, unless the context otherwise
requires. The word "including" shall mean including without limitation.

         (i) Successors and Assigns. This Credit Agreement shall be binding upon
and shall inure to the benefit of the Parties, and their respective successors
and assigns; provided, however, that Mediconsult or Physicians' Online may not
assign any of its rights hereunder without the prior written consent of Cybear.
Cybear may, without the consent of Mediconsult or Physicians' Online, assign,
negotiate, hypothecate, or grant participations in this Credit Agreement or in
any of its rights under this Credit Agreement. Cybear shall promptly notify
Mediconsult of any such assignment, negotiation, hypothecation or participation.
Mediconsult and Physicians' Online shall accord full recognition to any such
assignment, and all rights and remedies of Cybear in connection with the
interest so assigned shall be as fully enforceable by such assignee as they were
by Cybear before such assignment.

         (j) Limit on Interest. Anything herein or in the Note to the contrary
notwithstanding, the obligations of Mediconsult under this Credit Agreement and
the Note shall be subject to the

                                       14
<PAGE>

limitation that payments of interest shall not be required to the extent that
receipt of any such payment by Cybear would be contrary to provisions of law
applicable to Cybear (if any) that limit the maximum rate of interest that may
be charged or collected by such Lender. In the event that Mediconsult makes any
payment of interest, fees or other charges, however denominated, pursuant to
this Credit Agreement or the Note, which payment results in the interest paid by
Mediconsult to Cybear to exceed the maximum rate of interest permitted by
applicable law, any excess over such maximum shall be applied in reduction of
the principal balance owed to Cybear as of the date of such payment, or if such
excess exceeds the amount of principal owed to Cybear as of the date of such
payment, the difference shall be returned to Mediconsult.

         (k) Counterparts. This Credit Agreement may be executed in one or more
counterparts, each of which shall be deemed an original but all of which
together will constitute one and the same instrument.

         (l) Integration. This Credit Agreement, together with the Note,
constitutes the complete and integrated agreement of the parties hereto with
respect to the subject matter hereof and supersedes all prior agreements,
written or oral, on the subject matter hereof.

         (m) Waiver of Jury Trial. EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES
ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER
BASED ON CONTRACT, TORT, OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS CREDIT
AGREEMENT OR THE ACTIONS OF THE PARTIES IN THE NEGOTIATION, ADMINISTRATION,
PERFORMANCE AND ENFORCEMENT HEREOF. THIS PROVISION IS A MATERIAL INDUCEMENT FOR
MEDICONSULT ENTERING INTO THIS CREDIT AGREEMENT AND CYBEAR MAKING ANY LOAN,
ADVANCE OR OTHER EXTENSION OF CREDIT TO MEDICONSULT

         (n) Consent to Jurisdiction. Each of the Parties hereby irrevocably
submits to the exclusive jurisdiction of the courts of the State of Delaware and
the United States District Court for the State of Delaware, for the purpose of
any action or proceeding arising out of or relating to this Credit Agreement and
each of the Parties hereby irrevocably agrees that all claims in respect of such
action or proceeding may be heard and determined exclusively in any Delaware
state or federal court. Each of the Parties agrees that a final judgment in any
action or proceeding shall be conclusive and may be enforced in other
jurisdictions by suit on the judgment in any other matter provided by law.

                         [SIGNATURES ON FOLLOWING PAGE]

                                       15
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Credit
Agreement to be executed as of the date first above written.

                                       CYBEAR INC., a Delaware corporation

                                       By: /s/ Timothy Nolan
                                           -------------------------------------
                                           Timothy Nolan, President and COO

                                       MEDICONSULT.COM, a Delaware corporation

                                       By: /s/ Ian D. Sutcliffe
                                           -------------------------------------
                                           Ian D. Sutcliffe, Chief Executive
                                           Officer

                                       PHYSICIANS' ONLINE, INC., a Delaware
                                       corporation

                                       By: /s/ E. Michael Ingram
                                           -------------------------------------

                                       Name: E. Michael Ingram
                                            ------------------------------------

                                       Title: Secretary
                                             -----------------------------------

                                       16EXHIBIT 10.3

NEITHER THIS NOTE NOR THE COMMON STOCK ISSUABLE UPON CONVERSION HEREOF HAS BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
OR UNDER THE SECURITIES LAWS OF ANY STATE OR FOREIGN COUNTRY. THE SECURITIES
REPRESENTED HEREBY ARE RESTRICTED AND MAY NOT BE OFFERED, RESOLD, PLEDGED OR
TRANSFERRED EXCEPT IF SUCH TRANSACTION IS REGISTERED UNDER THE SECURITIES ACT
AND APPLICABLE STATE AND FOREIGN SECURITIES LAWS OR IF SUCH TRANSACTION IS
EXEMPT FROM SUCH REGISTRATION, IN THE OPINION OF COUNSEL TO THE COMPANY.

                         LINE OF CREDIT CONVERTIBLE NOTE

$2,000,000.00

                                                           Dated January 9, 2001

For value received, Mediconsult.com, Inc., a Delaware corporation
("Mediconsult"), and Physicians' Online, a Delaware corporation ("Physicians'
Online", and collectively with Mediconsult, the "Borrower"), promises to pay to
the order of Cybear Inc., a Delaware corporation ("Cybear") and a subsidiary of
Andrx Corporation, as hereinafter set forth, at the principal office of Cybear
at 5000 Blue Lake Drive, Suite 200, Boca Raton, Florida 33431, Attention: Scott
Lodin, Esq., the principal sum of Two Million and 00/100 Dollars ($2,000,000.00)
or such lesser amount as may have been advanced to the Borrower pursuant to the
Credit Agreement (hereinafter defined) in lawful money of the United States of
America, and to pay interest on the unpaid principal balance hereof in like
money at such office from the date hereof until the principal hereof shall have
become due and payable by acceleration or otherwise, at a rate per annum of Two
Percent (2%) greater than the "Prime Rate," as listed in the Money Rate section
of the Eastern Edition of The Wall Street Journal. On the day of a change in the
Prime Rate, the interest rate hereunder shall be automatically changed so that
the rate of interest shall continue to be Two Percent (2%) greater than the new
Prime Rate. Cybear shall not be required to notify the Borrower of any such
changes in the rate of interest.

         The principal amount of, and interest on, this Line of Credit
Convertible Note (the "Note") shall be due and payable on the Maturity Date (as
defined in the Credit Agreement) and subject to the terms and conditions of the
Credit Agreement between Mediconsult, Physicians' Online and Cybear of even date
herewith (the "Credit Agreement"). Capitalized terms used in this Note without
definition shall have the respective meanings given to them the Credit
Agreement.

         Subject to the provisions of this paragraph, the Borrower shall have
the right, at any time or from time to time, to prepay this Note in whole or in
part, without premium or penalty, provided, however, that the Borrower shall
give to Cybear at least three business days' prior

<PAGE>

written notice of the Borrower's intent to make any prepayment. Upon each
prepayment, the Borrower shall pay accrued interest on the principal amount so
prepaid to the date of prepayment. Each prepayment shall be applied to the last
installment or installments due hereunder in the inverse order of maturity.
Notwithstanding any notice of prepayment, Cybear shall be entitled to exercise
the conversion rights granted to it in this Note until the close of business on
the last business day before the date of such prepayment.

         If the principal of this Note or any portion hereof and, to the extent
permitted by law, interest hereon shall not be paid when due, whether by
acceleration or otherwise, the same shall bear interest for any period during
which the same shall be overdue at a rate per annum equal to the Default Rate
set forth in the Credit Agreement, and shall be payable on demand.

         This Note is the Note referred to in the Credit Agreement. Each holder
hereof is entitled to the benefits and security provided thereby or referred to
therein, to which Credit Agreement reference is hereby made for a statement
thereof. Reference is made to such Credit Agreement for rights as to the
acceleration of the maturity hereof.

         The entire unpaid principal balance of the Loan (as defined in the
Credit Agreement), together with all unpaid interest accrued thereon and all
other sums owing under this Note or any other instrument or document executed by
the Borrower in connection with the Loan, shall become immediately due and
payable without notice or demand upon an Event of Default on the terms set forth
in the Credit Agreement.

         The Borrower shall pay any present or future stamp or documentary taxes
or any other excise or property taxes, charges or similar levies that arise from
any payment made hereunder, or from the execution, delivery or registration of,
or otherwise with respect to, this Note.

         The Borrower agrees to pay all costs incurred by any holder hereof
(other than for the preparation of this Note, the Credit Agreement or any
related loan documents), including reasonable attorneys' fees (including those
for appellate proceedings), incurred in connection with any Event of Default (as
defined in the Credit Agreement), or in connection with the collection or
attempted collection or enforcement hereof, or in connection with the protection
of any collateral given as security, if any, for the payment hereof, whether or
not legal proceedings may have been instituted.

         All parties to this Note, including the Borrower and any sureties,
endorsers or guarantors, hereby waive presentment for payment, demand, protest,
notice of dishonor, notice of acceleration of maturity, and all defenses on the
ground of extension of time for payment hereof, and agree to continue and remain
bound for the payment of principal, interest and all other sums payable
hereunder, notwithstanding any change or changes by way of release, surrender,
exchange or substitution of any security for this Note, if any, or by way of any
extension or extensions of time for payment of principal or interest; and all
such parties waive all and every kind of notice of such change or changes and
agree that the same may be made without notice to or consent of any of them. The
rights and remedies of the holder as provided herein shall be cumulative and
concurrent and may be pursued singularly, successively or together at the sole
discretion of the holder, and may be exercised as often as occasion therefor
shall occur, and the

                                       2
<PAGE>

failure to exercise any such right or remedy shall in no event be construed as a
waiver or release of the same.

         Anything herein to the contrary notwithstanding, the obligations of the
Borrower under this Note shall be subject to the limitation that payments of
interest to Cybear shall not be required to the extent that receipt of any such
payment by Cybear would be contrary to provisions of law applicable to Cybear
(if any) limiting the maximum rate of interest that may be charged or collected
by Cybear. In the event that the Borrower makes any payment of interest, fees or
other charges, however denominated, pursuant to this Note, which payment results
in the interest paid to Cybear to exceed the maximum rate of interest permitted
by applicable law, any excess over such maximum shall be applied in reduction of
the principal balance owed to Cybear as of the date of such payment, or if such
excess exceeds the amount of principal owed to Cybear as of the date of such
payment, the difference shall be paid by Cybear to the Borrower.

         At any time on or after the date of termination of the Merger Agreement
prior to the consummation of the Merger, Cybear is entitled to convert the
unpaid principal amount of this Note or any portion thereof into a number of
shares of Mediconsult's common stock, par value $.001 per share (the "Common
Stock"), based upon a conversion price equal to $0.125 per share of Common Stock
(the "Conversion Price"); provided, however, that, for so long as the
Mediconsult Common Stock is listed for trading on the National Association of
Securities Dealers Automated Quotation System, Cybear may convert only so much
of the unpaid principal amount of this Note as results in Cybear's receipt of a
number of shares of Mediconsult Common Stock equal to a maximum of 19.9% of the
then outstanding shares of Mediconsult Common Stock, on a fully diluted basis.
The conversion shall be effective on the third business day following the
receipt by Mediconsult of the Notice of Conversion (as hereafter defined) from
Cybear.

         In order to convert this Note into Common Stock, Cybear must deliver an
irrevocable notice of conversion (the "Notice of Conversion"), in the form
attached hereto as Exhibit A. Notices of Conversion shall be deemed delivered on
the date sent, if personally delivered or sent by facsimile (with confirmation
of transmission) to Mediconsult's Chief Financial Officer at Mediconsult's
principal place of business, or when actually received if sent by another
method.

         Mediconsult shall use its reasonable best efforts to cause its transfer
agent to issue the Common Stock within three (3) business days after the Company
receives a fully executed Notice of Conversion. Mediconsult shall bear the cost
associated with the issuance of the Common Stock. The Common Stock shall be
issued with a restrictive legend indicating that it was issued in a transaction
in which the securities were not registered under the Securities Act, and that
it cannot be transferred unless it is so registered, or an exemption from
registration is available, in the opinion of counsel to Mediconsult. The Common
Stock shall be issued in the name of Cybear unless, in the opinion of counsel to
the Company, such transfer can be made in compliance with applicable securities
laws. The person in whose name the certificates of Common Stock are so
registered shall be treated as a common stockholder of Mediconsult beginning on
the date the Notice of Conversion is received by Mediconsult. If the Note is

                                       3
<PAGE>

converted in full, then Cybear shall deliver the Note to Mediconsult upon
Cybear's receipt of the certificates representing the Common Stock issuable upon
such conversion in full. If the Note is converted in part, then Cybear shall
deliver the Note to Mediconsult upon Cybear's receipt of the certificates
representing the Common Stock issuable upon such conversion in full and a new
Line of Credit Convertible Note in the maximum principal amount equal to the
unconverted portion of the maximum principal amount of the original Note.

         Following any conversion in whole or in part of this Note, Cybear may
by written notice (the "Registration Notice") to Mediconsult request Mediconsult
to register under the Securities Act all or any part of the shares of
Mediconsult Common Stock acquired pursuant to this Note, including any voting
securities issued by way of dividend, distribution or otherwise in respect
thereof (the "Restricted Shares"), beneficially owned by Cybear (the
"Registrable Securities") in order to permit the sale or other distribution of
such Registrable Securities, including pursuant to a firm commitment
underwritten public offering; provided, however, that any such Registration
Notice must relate to either (i) all of the shares of Mediconsult Common Stock
held by Cybear and its Affiliates or (ii)) such number of those shares that have
an aggregate fair market value of at least $2,500,000.00 and that any rights to
require registration hereunder shall terminate with respect to any shares that
may be sold in any 90-day period pursuant to Rule 144 under the Securities Act.
The Registration Notice shall include a certificate executed by Cybear and the
proposed managing underwriter, which underwriter shall be an investment banking
firm of nationally recognized standing (the "Manager") agreed to by Mediconsult
(which agreement shall not be unreasonably withheld or delayed), stating that
Manager in good faith believes that, based on the then prevailing market
conditions, it will be able to sell the Registrable Securities at a per share
price equal to at least 85% of the Market Price of such shares over the 10-day
trading period ending on the trading day immediately preceding the date of the
Registration Notice.

         Mediconsult shall use commercially reasonable efforts to effect, as
promptly as practicable, the registration under the Securities Act of the
unpurchased Registrable Securities; provided, however, that (i) Cybear shall not
be entitled to more than two effective registration statements hereunder and
(ii) Mediconsult will not be required to file any such registration statement
during any period of time (not to exceed 60 days after such request in the case
of clause (A) below or 90 days in the case of clauses (B) and (C) below) when
(A) Mediconsult is in possession of material non-public information which it
reasonably believes would be detrimental to be disclosed at such time and, based
on consultation with counsel to Mediconsult, such information would have to be
disclosed if a registration statement were filed at that time; (B) Mediconsult
is required under the Securities Act to include audited financial statements for
any period in such registration statement and such financial statements are not
yet available for inclusion in such registration statement; or (C) Mediconsult
determines, in its reasonable good faith, judgment, that such registration would
interfere with any financing, acquisition or other material transaction
involving Mediconsult or any of its Affiliates. Mediconsult shall use
commercially reasonable efforts to cause any Registrable Securities registered
pursuant to this Note to be qualified for sale under the securities or Blue Sky
laws of such jurisdictions as Cybear may reasonably request and shall continue
such registration or qualification in effect in such jurisdiction; provided,
however, that Mediconsult shall not be required to qualify to do business in, or
consent to general service of process in, any jurisdiction by reason of this
provision.

         The registration rights set forth in this Note are subject to the
condition that Cybear shall provide Mediconsult with such information with
respect to the Registrable Securities, the plans for the distribution thereof,
and such other information with respect to Cybear as, in the

                                       4
<PAGE>

reasonable judgment of counsel for Mediconsult, is necessary to enable
Mediconsult to include in such registration statement all material facts
required to be disclosed with respect to a registration thereunder.

         If Mediconsult securities of the same type as the Registrable
Securities are listed or admitted for trading on any United States national
securities exchange or automated quotations system, Mediconsult, upon the
request of Cybear, shall promptly file an application, if required, to authorize
for quotation, trading or listing the shares of Registrable Securities on such
exchange or system and will use its reasonable best efforts to obtain approval,
if required, of such quotation, trading or listing as soon as practicable.

         A registration effected under this Note shall be effected at
Mediconsult's expense, except for underwriting discounts and commissions and
fees and expenses of counsel to Cybear, and Mediconsult shall provide to the
underwriters such documentation (including certificates, opinions of counsel and
"comfort" letters from auditors) as are customary in connection with
underwritten public offerings as such underwriters may reasonably require. In
connection with any such registration, the Parties agree (i) to indemnify each
other and the underwriters in the customary manner and (ii) to enter into an
underwriting agreement in form and substance customary for transactions of the
type contemplated hereby with the Manager and the other underwriters
participating in such offering.

         The Conversion Price provided for herein shall be subject to the
following adjustments:

                  A. In the event of any change in Mediconsult Common Stock by
reason of stock dividends, splits, mergers (other than the Merger),
recapitalizations, combinations, exchange of shares or the like, the type and
number of shares or securities into which this Note is convertible, and the
Conversion Price per share, shall be adjusted appropriately, and proper
provision shall be made in the agreements governing such transaction so that
Cybear shall receive, upon conversion in whole or in part of this Note, the
number and class of shares or other securities or property that Cybear would
have received in respect of the Mediconsult Common Stock if the Note had been
converted immediately prior to such event or the record date therefor, as
applicable.

                  B. In the event that Mediconsult shall enter in an agreement:
(i) to consolidate with or merge into any person, other than in connection with
the Merger or into Cybear or any of its subsidiaries or affiliates, and shall
not be the continuing or surviving corporation of such consolidation or merger;
(ii) to permit any person, other than in connection with the Merger or Cybear or
one of its subsidiaries or affiliates, to merge into Mediconsult and Mediconsult
shall be the continuing or surviving corporation, but, in connection with such
merger, the then-outstanding shares of Mediconsult Common Stock shall be changed
into or exchanged for stock or other securities of Mediconsult or any other
person or cash or any other property or the outstanding shares of Mediconsult
Common Stock immediately prior to such merger shall after such merger represent
less than 50% of the outstanding shares and share equivalents of the merged
company; or (iii) to sell or otherwise transfer all or substantially all of its
assets to any person, other than Cybear or any of its subsidiaries or
affiliates, then, and in each such case, the agreement governing such
transaction shall make proper provision so that, upon the consummation of any
such transaction and upon the terms and conditions set forth herein,

                                       5
<PAGE>

Cybear shall be permitted to convert any portion of this Note that has not
previously been converted and receive for each Mediconsult Share with respect to
which the Note so converts an amount of consideration in the form of and equal
to the per share amount of consideration that would be received by the holder of
one share of Mediconsult Common Stock (and, in the event of an election or
similar arrangement with respect to the type of consideration to be received by
the holders of Common Stock, subject to the foregoing, proper provision shall be
made so that Cybear would have the same election or similar rights as would the
holder of the number of shares of Mediconsult Common Stock into which the Note
is then converted).

                  C. If Mediconsult shall issue, after the date upon which this
Note is first issued (the "Issue Date"), any Additional Stock (as defined below)
without consideration or for a consideration per share less than the Conversion
Price for the Note in effect immediately prior to the issuance of such
Additional Stock, the Conversion Price for the Note in effect immediately prior
to each such issuance shall forthwith (except as otherwise provided in this
clause (i)) be adjusted to a price determined by multiplying such Conversion
Price by a fraction, the numerator of which shall be the number of shares of
Mediconsult Common Stock outstanding immediately prior to such issuance plus the
number of shares of such Additional Stock that the aggregate consideration
received by Mediconsult for such issuance would purchase at such Conversion
Price; and the denominator of which shall be the number of shares of Mediconsult
Common Stock outstanding immediately prior to such issuance.

                     (ii)  No adjustment of the Conversion Price shall be made
in an amount less than one percent, provided that any adjustments which are not
required to be made by reason of this sentence shall be carried forward and
shall be taken into account together with any subsequent adjustment where the
aggregate adjustment is equal to or greater than one percent.

                     (iii) In the case of the issuance of Mediconsult Common
Stock for cash, the consideration shall be deemed to be the amount of cash paid
therefor before deducting any reasonable discounts, commissions or other
expenses allowed, paid or incurred by Mediconsult for any underwriting or
otherwise in connection with the issuance and sale thereof.

                     (iv)  In the case of the issuance of Mediconsult Common
Stock for a consideration in whole or in part other than cash, the consideration
other than cash shall be deemed to be the fair value thereof as determined by
the Board of Directors of Mediconsult irrespective of any accounting treatment.

                     (v)   In the case of the issuance (whether before, on or
after the applicable Issue Date) of options to purchase or rights to subscribe
for Mediconsult Common Stock, securities by their terms convertible into or
exchangeable for Mediconsult Common Stock or options to purchase or rights to
subscribe for such convertible or exchangeable securities, the following
provisions shall apply for all purposes of this Paragraph C(i) and Paragraph
C(ii):

                           a. The aggregate maximum number of shares of
Mediconsult Common Stock deliverable upon exercise (assuming the satisfaction of
any conditions to exercisability, including without limitation, the passage of
time, but without taking into account potential antidilution adjustments) (to
the extent then exercisable) of such options to purchase or rights to subscribe
for Mediconsult Common Stock shall be deemed to have been issued at the

                                       6
<PAGE>

time such options or rights were issued and for a consideration equal to the
consideration (determined in the manner provided in Paragraphs C(i) and C(ii)),
if any, received by Mediconsult upon the issuance of such options or rights plus
the minimum exercise price provided in such options or rights (without taking
into account potential antidilution adjustments) for the Mediconsult Common
Stock covered thereby.

                           b. The aggregate maximum number of shares of
Mediconsult Common Stock deliverable upon conversion of or in exchange (assuming
the satisfaction of any conditions to convertibility or exchangeability,
including, without limitation, the passage of time, but without taking into
account potential antidilution adjustments) (to the extent then convertible or
exchangeable) for any such convertible or exchangeable securities or upon the
exercise of options to purchase or rights to subscribe for such convertible or
exchangeable securities and subsequent conversion or exchange thereof shall be
deemed to have been issued at the time such securities were issued or such
options or rights were issued and for a consideration equal to the
consideration, if any, received by Mediconsult for any such securities and
related options or rights (excluding any cash received on account of accrued
interest or accrued dividends), plus the minimum additional consideration, if
any, to be received by Mediconsult (without taking into account potential
antidilution adjustments) upon the conversion or exchange of such securities or
the exercise of any related options or rights (the consideration in each case to
be determined in the manner provided in Paragraphs C(iii) and C(iv)).

                           c. In the event of any change in the number of shares
of Mediconsult Common Stock deliverable or in the consideration payable to
Mediconsult upon exercise of such options or rights or upon conversion of or in
exchange for such convertible or exchangeable securities, including, but not
limited to, a change resulting from the antidilution provisions thereof, the
Conversion Price, to the extent in any way affected by or computed using such
options, rights or securities, shall be recomputed to reflect such change, but
no further adjustment shall be made for the actual issuance of Mediconsult
Common Stock or any payment of such consideration upon the exercise of any such
options or rights or the conversion or exchange of such securities.

                           d. Upon the expiration of any such options or rights,
the termination of any such rights to convert or exchange or the expiration of
any options or rights related to such convertible or exchangeable securities,
the Conversion Price, to the extent in any way affected by or computed using
such options, rights or securities or options or rights related to such
securities, shall be recomputed to reflect the issuance of only the number of
shares of Mediconsult Common Stock (and convertible or exchangeable securities
which remain in effect) actually issued upon the exercise of such options or
rights, upon the conversion or exchange of such securities or upon the exercise
of the options or rights related to such securities.

                           e. The number of shares of Mediconsult Common Stock
deemed issued and the consideration deemed paid therefor pursuant to Paragraphs
C(v)(a) and C(v)(b) shall be appropriately adjusted to reflect any change,
termination or expiration of the type described in either Paragraph C(v)(c) or
C(v)(d).

                                       7
<PAGE>

                  (vi)     "Additional Stock" shall mean any shares of
Mediconsult Common Stock issued (or deemed to have been issued pursuant to
Paragraph C(v)(e)) by Mediconsult after the Issue Date other than:

                           a. shares of Mediconsult Common Stock issued pursuant
to a transaction described in Paragraph C(vii) hereof;

                           b. shares of Mediconsult Common Stock issuable or
issued to employees, consultants, directors or vendors (if in transactions with
primarily non-financing purposes) of Mediconsult directly or pursuant to a stock
option plan or restricted stock plan approved by the stockholders and Board of
Directors of Mediconsult, or shares of Mediconsult Common Stock issued to Cybear
or any of its subsidiaries or affiliates;

                           c. shares of Mediconsult Common Stock issued in
connection with a bona fide business acquisition of or by Mediconsult, whether
by merger, consolidation, sale of assets, sale or exchange of stock or
otherwise;

                           d. shares of Mediconsult Common Stock issued to any
bank, equipment or real property lessor or other similar institution if and to
the extent that the transaction in which such issuance is to be made is approved
by Mediconsult's Board of Directors; or

                           e. shares of Mediconsult Common Stock issued pursuant
to or in connection with any corporate partnership, joint venture, or other
arrangement if and to the extent that the transaction in which such issuance is
to be made is approved by Mediconsult's Board of Directors.

                  (vii)    In the event Mediconsult should at any time or from
time to time after the Issue Date fix a record date for the effectuation of a
split or subdivision of the outstanding shares of Mediconsult Common Stock or
the determination of holders of Mediconsult Common Stock entitled to receive a
dividend or other distribution payable in additional shares of Mediconsult
Common Stock or other securities or rights convertible into, or entitling the
holder thereof to receive directly or indirectly, additional shares of
Mediconsult Common Stock (hereinafter referred to as "Common Stock Equivalents")
without payment of any consideration by such holder for the additional shares of
Mediconsult Common Stock or the Common Stock Equivalents (including the
additional shares of Mediconsult Common Stock issuable upon conversion or
exercise thereof), then, as of such record date (or the date of such dividend
distribution, split or subdivision if no record date is fixed), the Conversion
Price shall be appropriately decreased so that the number of shares of
Mediconsult Common Stock issuable on conversion of this Note shall be increased
in proportion to such increase in the aggregate of shares of Mediconsult Common
Stock outstanding and those issuable with respect to such Common Stock
Equivalents with the number of shares issuable with respect to Common Stock
Equivalents determined from time to time in the manner provided for deemed
issuances in Paragraph C(v)(e).

                  (viii)   If the number of shares of Mediconsult Common Stock
outstanding at any time after the Issue Date is decreased by a combination of
the outstanding

                                       8
<PAGE>

shares of Mediconsult Common Stock, then, following the record date of such
combination, the Conversion Price shall be appropriately increased so that the
number of shares of Mediconsult Common Stock issuable on conversion of this Note
shall be decreased in proportion to such decrease in outstanding shares.

         Mediconsult shall at all times reserve and keep available out of its
authorized but unissued shares of Common Stock, such number of its shares of
Common Stock as shall from time to time be sufficient to effect the conversion
of the Note, the sufficiency of which shall be determined by using the
Conversion Price.

         Subject to prior conversion in whole or in part, no provision of this
Note shall alter or impair the obligation of the Borrower, which is absolute and
unconditional, to pay the principal of, and interest on, this Note at the time,
place, and rate, and in the manner herein prescribed. This Note is a direct
obligation of the Borrower.

         Cybear, by acceptance hereof, represents that it is an "accredited
investor" as defined in the Securities Act and the rules promulgated thereunder,
and agrees that this Note is being acquired for investment and not with a view
to the distribution thereof, and that it will not offer, sell or otherwise
dispose of this Note or the shares of Common Stock issuable upon conversion
thereof except under circumstances that will not result in a violation of the
Securities Act or any applicable state "blue sky" laws or similar state or
foreign laws relating to the sale of securities. Unless the issuance of the
shares of Common Stock issuable upon conversion of this Note shall have been
registered under the Securities Act, Cybear, by tendering notice to the Company
of its intent to convert all or part of this Note pursuant to the provisions
hereof, shall be deemed to represent to Mediconsult that Cybear is acquiring
such shares of Common Stock for investment and not with a view to the
distribution thereof.

         Nothing contained in this Note shall be construed as conferring upon
Cybear the right to vote or to receive dividends or to consent or receive notice
as a shareholder in respect of any meeting of shareholders or any rights
whatsoever as a shareholder of Mediconsult, unless and to the extent this Note
is converted in accordance with the terms hereof.

         THE BORROWER HEREBY, AND CYBEAR BY ITS ACCEPTANCE OF THIS NOTE,
KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THE RIGHT EITHER MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF,
UNDER OR IN CONNECTION WITH THIS NOTE OR SAID CREDIT AGREEMENT AND ANY AGREEMENT
CONTEMPLATED TO BE EXECUTED IN CONJUNCTION HEREWITH, OR ANY COURSE OF CONDUCT,
COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF EITHER
PARTY. THIS PROVISION IS A MATERIAL INDUCEMENT FOR CYBEAR ENTERING INTO SAID
CREDIT AGREEMENT AND MAKING THE LOAN EVIDENCED BY THIS NOTE.

         This Note shall be governed by and construed in accordance with the
laws of the State of Delaware.

                                       9
<PAGE>

         IN WITNESS WHEREOF, the Borrower has caused this Note to be executed as
of the date first above written.

                                       MEDICONSULT.COM, INC., a Delaware
                                       corporation

                                       By: /s/ Ian Sutcliffe
                                          --------------------------------------
                                          Ian Sutcliffe, Chief Executive Officer

                                       PHYSICIANS' ONLINE, INC., a Delaware
                                       corporation

                                       By: /s/ E. Michael Ingram
                                          --------------------------------------

                                       Name:  E. Michael Ingram
                                            ------------------------------------

                                       Title: Secretary
                                             -----------------------------------

                                       10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00019-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00019-of-00352.parquet"}]]